润都股份：关于坎地沙坦酯片获得药品注册证书的公告

Group 1 - The core point of the article is that Rundu Co., Ltd. has received a drug registration certificate for Candesartan Cilexetil Tablets from the National Medical Products Administration [2] Group 2 - The announcement was made on February 9, indicating a significant regulatory milestone for the company [2] - The approval of the drug may open new market opportunities for Rundu Co., Ltd. in the pharmaceutical sector [2] - This development highlights the company's ongoing efforts to expand its product portfolio and enhance its competitive position in the industry [2]